Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors
about
Psychomotor retardation in depression: biological underpinnings, measurement, and treatmentThe noradrenergic paradox: implications in the management of depression and anxietySKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activityPharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorderEffect of enhanced voluntary physical exercise on brain levels of monoamines in Huntington disease miceNovel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.Potential benefits of berberine in the management of perimenopausal syndrome.Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?MPTP Impairs Dopamine D1 Receptor-Mediated Survival of Newborn Neurons in Ventral Hippocampus to Cause Depressive-Like Behaviors in Adult Mice.Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.5-HT2 ligands in the treatment of anxiety and depression.Novel agents in development for the treatment of depression.An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.Neuromodulatory signaling in hippocampus-dependent memory retrieval.Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.Modulation of dopamine-dependent behaviors by the Caenorhabditis elegans Olig homolog HLH-17.Echinocystic acid reduces reserpine-induced pain/depression dyad in mice.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.Effects of repeated electroconvulsive shocks on catecholamine systems: electrophysiological studies in the rat brain.Emerging drugs for major depressive disorder: an update.Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs).
P2860
Q24629825-51C38DF5-A882-4DB2-B97C-823372F28A66Q26752868-4C320F0B-0103-4E6E-8F24-F1960DB9CC28Q28295413-48BB2B65-7D30-402E-BDAD-DBE6D14F2D85Q28545209-2050D08E-5A8B-4B74-909A-D0419EEE733EQ28744585-A387AD7F-6827-466C-89ED-C33A87C1B453Q34135360-67EBF5E7-4AB5-47A8-AE67-4AEC5CC8EAE4Q34980328-B930E547-3E42-438A-972D-EAE717D423BAQ35138347-6BC238B7-57E2-4E9C-899D-BCD48030C555Q36902050-6B2A9331-E088-4B0F-B537-28F8E7CD27F3Q37158450-D6937271-3064-46E3-BF62-26B37DD553BBQ37335443-9AFE7635-029A-422B-A59C-8098B11C3614Q37552410-689BA657-AA4A-4DCF-B309-E7320E0BD5B6Q37734565-256C0A5E-EFF5-4CD4-AB00-1B962FEC5CBFQ37891098-4CBEDC80-CC3A-4A4E-B85C-FE7E14602A30Q38037141-51738BE6-BBC3-40AA-8D60-ED803EB92BA5Q38164163-922DE9F5-E9DD-4F1F-91A2-87DEC24DE2FAQ38167857-F0393639-0673-4FF8-B749-05B8AC79B852Q38283275-E657F6FB-63DD-4BBC-806E-AFD55E154A44Q38369297-ECA3EDD8-93D6-46EA-91AF-0014F0350680Q42490242-B3FA43E5-E962-465B-B1A6-C82982D1B4A6Q48067098-1263CC67-0AA8-491A-8E9E-CAD30D0415AAQ48250330-0488FB40-943A-442A-B133-0646E68FCF49Q48465348-1D75ED8B-2B0E-47C7-99AB-30EB5485EF32Q48692644-C4266EE2-0911-46B9-8493-0B4830FE40AAQ55421497-7EE17292-4A9E-41DC-9E49-2F41D6FBB1A4
P2860
Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@ast
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@en
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@nl
type
label
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@ast
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@en
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@nl
prefLabel
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@ast
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@en
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@nl
P2093
P3181
P1433
P1476
Prospect of a dopamine contrib ...... the triple reuptake inhibitors
@en
P2093
Bruno P Guiard
Mostafa El Mansari
Pierre Blier
P304
P3181
P356
10.2174/138945009789735156
P407
P577
2009-11-01T00:00:00Z